Curi Bio, a leader in developing human stem cell-based platforms for drug discovery, has announced a Memorandum of Understanding for scientific collaboration with Genetox and DreamCIS

Alpha Cognition Inc, also known as Alpha Cognition, a biopharmaceutical company focused on developing novel treatments for severe neurodegenerative disorders, is excited to announce the submission of a new

MRM Health, a biopharmaceutical company in the clinical stage, has received approval from regulatory and ethics committees to commence an observational cross-sectional clinical trial. This trial aims to identify specific microbial and metabolic patterns

Disc Medicine, Inc, a biopharmaceutical company focusing on innovative treatments for severe hematologic diseases, has announced that the United States Food and Drug Administration

AffaMed Therapeutics, a prominent biotechnology company specializing in developing and commercializing innovative pharmaceutical and surgical products for unmet needs in ophthalmology

Certa Therapeutics, a biotechnology company specializing in precision therapies for inflammatory and fibrotic diseases, has announced that the U.S. Food and Drug Administration has granted Fast Track Designation for its investigational therapy

Iovance Biotherapeutics, Inc, a biotechnology company focused on developing novel polyclonal tumor infiltrating lymphocyte cell therapies for cancer patients, has received approval from the U.S. Food and Drug Administration

Intellia Therapeutics, Inc. and ReCode Therapeutics have announced a collaborative effort to develop innovative genomic medicines for cystic fibrosis, a genetic disease that affects various organs,

Bristol Myers Squibb has shared that the U.S. Food and Drug Administration accepted the supplemental New Drug Application for Augtyro™ aimed at treating solid tumors in adults and pediatric patients aged 12 and above

Atara Biotherapeutics, Inc, a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases,